Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke: A Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Clinical Trial

NCT07501533 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wannan Medical College as lead sponsor.

NCT NCT07501533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07501533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke: A Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Clinical Trial
Lead sponsor
First Affiliated Hospital of Wannan Medical College
Phase
Phase 2
Overall status
Recruiting
Start date
June 18, 2026
Completion date
March 31, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe stroke